The need for a second dose of ceftriaxone in febrile infants age 4-8 weeks

Sheryl Allen, Christine M. Walsh-Kelly, Halim H. Hennes

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To determine if a second intramuscular injection of ceftriaxone was necessary in febrile infants who meet low-risk criteria for outpatient therapy. Setting: Children's Hospital Emergency Department. Patients: Febrile infants 4-8 weeks of age. Methods: Outpatient treatment criteria included nontoxic appearance, no identifiable source for infection on physical examination, CSF WBC ≥10/mm3, peripheral WBC ≤ 15,000/mm3, normal UA, and normal chest radiograph study, if obtained. Additional requirements included a reliable caretaker and re-evaluation in 24 hours. Infants who met these criteria received intramuscular ceftriaxone 50 mg/kg with instructions to follow-up in 24 hours. At the follow-up visit, infants with no identifiable source for infection and negative cultures received a second dose of intramuscular ceftriaxone and were discharged. Cultures were read at 48 hours and at the conclusion of the study. Medical records were reviewed to identify delayed complications. Results: 172 infants were enrolled. The mean age was 45 days. All CBC, UA, CSF analyses were normal. Chest radiographs were obtained in 56 (30%) infants; all were normal. One (.05%) patient was admitted at the follow-up visit. The mean time to follow- up was 25 hours. Two positive cultures were identified at the re-evaluation visit; one blood culture grew Salmonella and a urine culture grew E. coli. The CSF cultures were all negative at follow-up and remained negative. Conclusion: Febrile infants 4-8 weeks of age who meet outpatient therapy criteria and have negative cultures and no identifiable source for infection at 24 hours may not require the second dose of intramuscular ceftriaxone.

Original languageEnglish (US)
Pages (from-to)60-62
Number of pages3
JournalWisconsin Medical Journal
Volume99
Issue number2
StatePublished - 2000
Externally publishedYes

Fingerprint

Ceftriaxone
Fever
Outpatients
Thorax
Infection
Intramuscular Injections
Hospital Departments
Salmonella
Physical Examination
Medical Records
Hospital Emergency Service
Therapeutics
Urine
Escherichia coli

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The need for a second dose of ceftriaxone in febrile infants age 4-8 weeks. / Allen, Sheryl; Walsh-Kelly, Christine M.; Hennes, Halim H.

In: Wisconsin Medical Journal, Vol. 99, No. 2, 2000, p. 60-62.

Research output: Contribution to journalArticle

Allen, Sheryl ; Walsh-Kelly, Christine M. ; Hennes, Halim H. / The need for a second dose of ceftriaxone in febrile infants age 4-8 weeks. In: Wisconsin Medical Journal. 2000 ; Vol. 99, No. 2. pp. 60-62.
@article{864c0665308349d9b3485fad72f8881f,
title = "The need for a second dose of ceftriaxone in febrile infants age 4-8 weeks",
abstract = "Objective: To determine if a second intramuscular injection of ceftriaxone was necessary in febrile infants who meet low-risk criteria for outpatient therapy. Setting: Children's Hospital Emergency Department. Patients: Febrile infants 4-8 weeks of age. Methods: Outpatient treatment criteria included nontoxic appearance, no identifiable source for infection on physical examination, CSF WBC ≥10/mm3, peripheral WBC ≤ 15,000/mm3, normal UA, and normal chest radiograph study, if obtained. Additional requirements included a reliable caretaker and re-evaluation in 24 hours. Infants who met these criteria received intramuscular ceftriaxone 50 mg/kg with instructions to follow-up in 24 hours. At the follow-up visit, infants with no identifiable source for infection and negative cultures received a second dose of intramuscular ceftriaxone and were discharged. Cultures were read at 48 hours and at the conclusion of the study. Medical records were reviewed to identify delayed complications. Results: 172 infants were enrolled. The mean age was 45 days. All CBC, UA, CSF analyses were normal. Chest radiographs were obtained in 56 (30{\%}) infants; all were normal. One (.05{\%}) patient was admitted at the follow-up visit. The mean time to follow- up was 25 hours. Two positive cultures were identified at the re-evaluation visit; one blood culture grew Salmonella and a urine culture grew E. coli. The CSF cultures were all negative at follow-up and remained negative. Conclusion: Febrile infants 4-8 weeks of age who meet outpatient therapy criteria and have negative cultures and no identifiable source for infection at 24 hours may not require the second dose of intramuscular ceftriaxone.",
author = "Sheryl Allen and Walsh-Kelly, {Christine M.} and Hennes, {Halim H.}",
year = "2000",
language = "English (US)",
volume = "99",
pages = "60--62",
journal = "Wisconsin Medical Journal",
issn = "1098-1861",
publisher = "State Medical Society of Wisconsin",
number = "2",

}

TY - JOUR

T1 - The need for a second dose of ceftriaxone in febrile infants age 4-8 weeks

AU - Allen, Sheryl

AU - Walsh-Kelly, Christine M.

AU - Hennes, Halim H.

PY - 2000

Y1 - 2000

N2 - Objective: To determine if a second intramuscular injection of ceftriaxone was necessary in febrile infants who meet low-risk criteria for outpatient therapy. Setting: Children's Hospital Emergency Department. Patients: Febrile infants 4-8 weeks of age. Methods: Outpatient treatment criteria included nontoxic appearance, no identifiable source for infection on physical examination, CSF WBC ≥10/mm3, peripheral WBC ≤ 15,000/mm3, normal UA, and normal chest radiograph study, if obtained. Additional requirements included a reliable caretaker and re-evaluation in 24 hours. Infants who met these criteria received intramuscular ceftriaxone 50 mg/kg with instructions to follow-up in 24 hours. At the follow-up visit, infants with no identifiable source for infection and negative cultures received a second dose of intramuscular ceftriaxone and were discharged. Cultures were read at 48 hours and at the conclusion of the study. Medical records were reviewed to identify delayed complications. Results: 172 infants were enrolled. The mean age was 45 days. All CBC, UA, CSF analyses were normal. Chest radiographs were obtained in 56 (30%) infants; all were normal. One (.05%) patient was admitted at the follow-up visit. The mean time to follow- up was 25 hours. Two positive cultures were identified at the re-evaluation visit; one blood culture grew Salmonella and a urine culture grew E. coli. The CSF cultures were all negative at follow-up and remained negative. Conclusion: Febrile infants 4-8 weeks of age who meet outpatient therapy criteria and have negative cultures and no identifiable source for infection at 24 hours may not require the second dose of intramuscular ceftriaxone.

AB - Objective: To determine if a second intramuscular injection of ceftriaxone was necessary in febrile infants who meet low-risk criteria for outpatient therapy. Setting: Children's Hospital Emergency Department. Patients: Febrile infants 4-8 weeks of age. Methods: Outpatient treatment criteria included nontoxic appearance, no identifiable source for infection on physical examination, CSF WBC ≥10/mm3, peripheral WBC ≤ 15,000/mm3, normal UA, and normal chest radiograph study, if obtained. Additional requirements included a reliable caretaker and re-evaluation in 24 hours. Infants who met these criteria received intramuscular ceftriaxone 50 mg/kg with instructions to follow-up in 24 hours. At the follow-up visit, infants with no identifiable source for infection and negative cultures received a second dose of intramuscular ceftriaxone and were discharged. Cultures were read at 48 hours and at the conclusion of the study. Medical records were reviewed to identify delayed complications. Results: 172 infants were enrolled. The mean age was 45 days. All CBC, UA, CSF analyses were normal. Chest radiographs were obtained in 56 (30%) infants; all were normal. One (.05%) patient was admitted at the follow-up visit. The mean time to follow- up was 25 hours. Two positive cultures were identified at the re-evaluation visit; one blood culture grew Salmonella and a urine culture grew E. coli. The CSF cultures were all negative at follow-up and remained negative. Conclusion: Febrile infants 4-8 weeks of age who meet outpatient therapy criteria and have negative cultures and no identifiable source for infection at 24 hours may not require the second dose of intramuscular ceftriaxone.

UR - http://www.scopus.com/inward/record.url?scp=0034083096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034083096&partnerID=8YFLogxK

M3 - Article

C2 - 10843028

AN - SCOPUS:0034083096

VL - 99

SP - 60

EP - 62

JO - Wisconsin Medical Journal

JF - Wisconsin Medical Journal

SN - 1098-1861

IS - 2

ER -